In the global efforts to combat the coronavirus pandemic, testing has proven to be a main challenge.
Location / Corona UPDATE
With the entire world looking for responses to the coronavirus pandemic, Germany’s pharmaceutical companies are attracting considerable attention. We asked Han Steutel, the president of the German Association of Research-Based Pharmaceutical Companies, for an update on the progress in developing anti-corona medications.
German government ministries and a state bank have commenced a “Special Plan 2020” to save companies from bankruptcy because of the virus.
The country’s many centers of research excellence will now be centrally linked to speed efforts to combat the pandemic.
The health care division of world-renowned German company Bosch announced on March 26 that it has developed a test kit for COVID-19 and nine other viral respiratory illnesses.
The German government is readying a massive cash injection to help innovative young companies ride out economic difficulties.
German companies are at the heart of the emergency development of potential coronavirus vaccines. That’s no accident considering Germany’s importance in both the pharmaceutical and biotechnology sectors. Germany Trade & Invest Director of Chemicals and Health Marcus Schmidt gives us the lowdown on this crucial area.